Clinical Trials in Baltimore

Showing 3161-3180 of 20,142 trials

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

NCT03077451

This pilot phase II trial studies how well nelfinavir mesylate works in treating patients with kaposi sarcoma. Nelfinavir mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recurrent Kaposi SarcomaSkin Kaposi Sarcoma

AIDS Malignancy Consortium36 participantsStarted Mar 2017

Miami, Florida, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

NCT04977986

This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). Eligible participants will participate in up to an 18-week treatment period, where all participants will receive placebo or active study drug. Patients ages 3 to \< 30 years will be eligible to participate.

Fragile X Syndrome

Zynerba Pharmaceuticals, Inc.215 participantsStarted Sep 2021

Phoenix, Arizona, United States • Culver City, California, United States • Irvine, California, United States +24 more locations

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

Find Trials by Condition in Baltimore

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Emergency Preservation and Resuscitation (EPR) for Cardiac Arrest From Trauma

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

A Peer-Led Intervention to Improve Postpartum Retention in HIV Care

Dose of Vestibular Rehabilitation for Vestibular Hypofunction

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

A Trial of Varenicline for E-cigarette Cessation

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG